Research Paper

Core Innovation

This paper introduces GPCR-Filter, which integrates a protein language model (ESM-3) for high-fidelity GPCR sequence representation with graph neural networks encoding ligand structures. An attention-based fusion mechanism learns receptor-ligand functional relationships, outperforming prior compound-protein interaction models and generalizing to unseen data.

Why It Matters

Discovering GPCR modulators is critical for drug development but hindered by complex receptor dynamics and costly assays. GPCR-Filter reduces time and cost by accurately predicting functional ligand effects, enabling scalable screening and faster therapeutic innovation across diverse GPCR targets.

Potential Customers & Pain Points

• Pharmaceutical companies – Slow and costly GPCR drug discovery
• Biotech startups – Need efficient screening tools for GPCR targets
• Academic researchers – Limited access to high-throughput functional assays
• Contract research organizations – Demand scalable computational methods for compound prioritization

Business Model

Subscription-based SaaS platform offering GPCR modulator prediction APIs and custom screening services to pharma and biotech clients.

Competitive Landscape

• Atomwise
• Exscientia
• Insilico Medicine
• BenevolentAI

Implementation Challenges

• Integration with existing drug discovery pipelines
• Validation of predicted modulators in biological assays
• Competition from established AI drug discovery platforms

Validation Strategy

• Benchmark against state-of-the-art compound-protein interaction models
• Collaborate with pharma partners to test predicted modulators experimentally
• Publish case studies demonstrating successful identification of novel GPCR agonists